US Stock MarketDetailed Quotes
BLFS BioLife Solutions
- 25.530
- -0.230-0.89%
Trading Aug 16 13:05 ET
1.18BMarket Cap-15472P/E (TTM)
25.920High25.290Low113.21KVolume25.660Open25.760Pre Close2.90MTurnover0.31%Turnover RatioLossP/E (Static)46.14MShares26.73052wk High3.66P/B920.76MFloat Cap8.92052wk Low--Dividend TTM36.07MShs Float72.188Historical High--Div YieldTTM2.45%Amplitude0.140Historical Low25.594Avg Price1Lot Size
BioLife Solutions Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.11%28.33M | -15.85%31.73M | -11.43%143.27M | -26.04%32.73M | -18.21%33.33M | -27.87%29.24M | 4.09%37.7M | 35.75%161.76M | 18.64%44.26M | 20.55%40.75M |
| Operating revenue | -3.11%28.33M | -15.85%31.73M | -11.43%143.27M | -26.04%32.73M | -18.21%33.33M | -27.87%29.24M | 4.09%37.7M | 35.75%161.76M | 18.64%44.26M | 20.55%40.75M |
| Cost of revenue | -26.23%13.44M | -19.01%19.17M | -10.58%96.52M | -22.47%23.48M | -19.73%21.68M | -30.47%18.21M | -3.20%23.66M | 31.46%107.94M | -2.74%30.29M | 8.63%27.01M |
| Gross profit | 35.10%14.89M | -10.53%12.56M | -13.14%46.75M | -33.79%9.25M | -15.21%11.65M | -23.12%11.02M | 19.24%14.04M | 45.28%53.82M | 126.62%13.97M | 53.74%13.74M |
| Operating expense | -21.63%17.69M | -16.61%22.45M | 11.26%104.29M | -5.57%22.82M | 14.68%26.53M | -3.37%22.57M | 16.73%26.92M | 38.46%93.74M | 5.89%24.17M | 16.30%23.13M |
| Selling and administrative expenses | -17.13%14.4M | -15.53%18M | 15.98%80.31M | -5.58%17.51M | 14.98%19.77M | 1.78%17.37M | 29.79%21.31M | 45.24%69.24M | 13.14%18.54M | 21.55%17.19M |
| -Selling and marketing expense | -8.59%3.5M | -21.65%5.07M | 13.97%24.58M | -23.97%4.54M | 37.48%7.26M | -29.25%3.83M | 32.30%6.47M | 54.01%21.57M | 24.93%5.97M | 29.84%5.28M |
| -General and administrative expense | -19.54%10.89M | -12.86%12.93M | 16.90%55.73M | 3.15%12.97M | 5.01%12.51M | 16.20%13.54M | 28.73%14.84M | 41.59%47.67M | 8.29%12.57M | 18.20%11.92M |
| Research and development costs | -37.20%2.38M | -14.88%3.53M | 27.02%18.8M | 5.64%4.4M | 57.72%5.4M | 10.65%3.79M | 9.81%4.15M | 25.18%14.8M | 16.61%4.16M | 6.40%3.43M |
| Depreciation amortization depletion | -35.28%910K | -37.35%914K | -46.57%5.18M | -37.37%915K | -46.04%1.36M | -50.89%1.41M | -49.04%1.46M | 18.23%9.7M | -48.95%1.46M | -0.48%2.51M |
| -Depreciation and amortization | -35.28%910K | -37.35%914K | -46.57%5.18M | -37.37%915K | -46.04%1.36M | -50.89%1.41M | -49.04%1.46M | 18.23%9.7M | -48.95%1.46M | -0.48%2.51M |
| Operating profit | 75.79%-2.8M | 23.24%-9.89M | -44.15%-57.53M | -33.10%-13.57M | -58.38%-14.88M | -28.02%-11.55M | -14.12%-12.89M | -30.23%-39.91M | 38.79%-10.2M | 14.24%-9.39M |
| Net non-operating interest income expense | 6.72%-361K | 49.64%-207K | -163.76%-1.81M | -16.02%-507K | -3,073.33%-476K | -1,109.38%-387K | -123.37%-411K | -41.65%-687K | -183.77%-437K | 92.27%-15K |
| Non-operating interest expense | -6.72%361K | -49.64%207K | ---- | ---- | 3,073.33%476K | 1,109.38%387K | 123.37%411K | ---- | ---- | --15K |
| Total other finance cost | ---- | ---- | 163.76%1.81M | ---- | ---- | ---- | ---- | 41.65%687K | ---- | ---- |
| Other net income (expense) | -162.18%-3.99M | 102.45%8K | 93.37%-6.91M | 101.69%652K | -806.64%-13.66M | 109.50%6.42M | -109.44%-326K | -5,044.35%-104.23M | -2,454.00%-38.64M | -124.15%-1.51M |
| Gain on sale of security | ---4.07M | ---- | ---- | ---- | ---- | ---- | ---- | 676.03%697K | --0 | --697K |
| Special income (charges) | --0 | 67.08%-237K | 92.26%-8.18M | 101.06%415K | -492.71%-13.91M | 108.93%6.03M | -121.66%-720K | -5,544.74%-105.63M | -2,060.09%-39.08M | -137.56%-2.35M |
| -Less：Restructuring and merger&acquisition | --0 | -67.08%237K | -54.31%-7.31M | 70.10%-415K | -167.35%-1.58M | -156.07%-6.03M | 121.66%720K | -144.12%-4.74M | -176.73%-1.39M | 137.56%2.35M |
| -Less:Impairment of capital assets | ---- | ---- | -85.97%15.49M | --0 | --15.49M | ---- | ---- | --110.36M | --40.46M | --0 |
| Other non- operating income (expenses) | -78.13%84K | -37.82%245K | 79.55%1.26M | -45.39%237K | 70.42%242K | 1,845.45%384K | 200.76%394K | 143.60%704K | 46.62%434K | 2,128.57%142K |
| Income before tax | -29.55%-7.15M | 25.93%-10.09M | 54.25%-66.26M | 72.75%-13.43M | -165.82%-29.02M | 92.80%-5.52M | -69.85%-13.62M | -398.96%-144.83M | -168.92%-49.27M | -122.37%-10.92M |
| Income tax | 0 | 42.39%131K | 103.37%169K | 49.41%-43K | 119.20%115K | 100.05%2K | 115.36%92K | 75.04%-5.02M | 96.70%-85K | 87.99%-599K |
| Net income | -103.15%-20.72M | 25.47%-10.22M | 52.49%-66.43M | 72.79%-13.38M | -182.37%-29.13M | 86.01%-10.2M | -84.80%-13.71M | -1,469.43%-139.81M | -212.41%-49.19M | -13,159.49%-10.32M |
| Net income continuous Operations | -29.50%-7.15M | 25.47%-10.22M | 52.49%-66.43M | 72.79%-13.38M | -182.37%-29.13M | 92.43%-5.52M | -84.80%-13.71M | -1,469.43%-139.81M | -212.41%-49.19M | -13,159.49%-10.32M |
| Net income discontinuous operations | -189.96%-13.57M | ---- | ---- | ---- | ---- | ---4.68M | ---- | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -103.15%-20.72M | 25.47%-10.22M | 52.49%-66.43M | 72.79%-13.38M | -182.37%-29.13M | 86.01%-10.2M | -84.80%-13.71M | -1,469.43%-139.81M | -212.41%-49.19M | -13,159.49%-10.32M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -103.15%-20.72M | 25.47%-10.22M | 52.49%-66.43M | 72.79%-13.38M | -182.37%-29.13M | 86.01%-10.2M | -84.80%-13.71M | -1,469.43%-139.81M | -216.76%-49.19M | -13,498.70%-10.32M |
| Basic earnings per share | -95.65%-0.45 | 31.25%-0.22 | 53.80%-1.52 | 73.91%-0.3 | -179.17%-0.67 | 86.63%-0.23 | -77.78%-0.32 | -1,330.43%-3.29 | -210.81%-1.15 | -12,852.39%-0.24 |
| Diluted earnings per share | -95.65%-0.45 | 31.25%-0.22 | 53.80%-1.52 | 73.91%-0.3 | -179.17%-0.67 | 86.63%-0.23 | -77.78%-0.32 | -1,330.43%-3.29 | -210.81%-1.15 | -13,598.31%-0.24 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg